tiprankstipranks
Tyra Biosciences price target lowered to $30 from $32 at H.C. Wainwright
PremiumThe FlyTyra Biosciences price target lowered to $30 from $32 at H.C. Wainwright
3M ago
Tyra Biosciences’ Q3 2024: Clinical Progress and Financial Resilience
Premium
Company Announcements
Tyra Biosciences’ Q3 2024: Clinical Progress and Financial Resilience
4M ago
Tyra Biosciences reports Q3 EPS (41c), consensus (40c)
Premium
The Fly
Tyra Biosciences reports Q3 EPS (41c), consensus (40c)
4M ago
Tyra Bioscience Shows Promise with TYRA-300 Results
PremiumCompany AnnouncementsTyra Bioscience Shows Promise with TYRA-300 Results
4M ago
Tyra Biosciences’ TYRA-300 shows anti-tumor activity in proof-of-concept trial
Premium
The Fly
Tyra Biosciences’ TYRA-300 shows anti-tumor activity in proof-of-concept trial
4M ago
Tyra Biosciences upgraded to Buy from Neutral at BofA
Premium
The Fly
Tyra Biosciences upgraded to Buy from Neutral at BofA
4M ago
Tyra Biosciences appoints Doug Warner as Chief Medical Officer
PremiumThe FlyTyra Biosciences appoints Doug Warner as Chief Medical Officer
6M ago
Tyra Biosciences appoints Doug Warner as Chief Medical Officer
Premium
The Fly
Tyra Biosciences appoints Doug Warner as Chief Medical Officer
6M ago
Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls
Premium
The Fly
Brinker upgraded, Snowflake downgraded: Wall Street’s top analyst calls
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100